참고문헌
- Anderson KE, Mack TM, Silverman DT (2006). Cancer Epidemiology and Prevention, New York: Oxford University Press.
- Miladinov-Mikov M, Dugandzija T (2013). Letter to the editor. Arch Oncol, 21, 53
- Engin H, Bilir C, Ustun H, Gokmen A (2012). ABO blood group and risk of pancreatic cancer in a Turkish population in western blacksea region. Asian Pac J Cancer Prev, 13, 131-3 https://doi.org/10.7314/APJCP.2012.13.1.131
- Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al (2013). Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer, 49, 374-1403.
- Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012.Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from:http://globocan.iarc.fr.
- Ghadirian P, Lynch HT, Krewski D (2003). Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev, 27, 87-93. https://doi.org/10.1016/S0361-090X(03)00002-3
- Hamilton S.R., Aaltonen L.A., (2000). Pathology and Genetics of Tumours of the Digestive System[e-book], Lyon:IARC Press.
- Howlader N, Noone AM, Krapcho M, et al (2012). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda.
- http://www.ncrc.ac.rs/strane/rakpankreasa.htm
- http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.
- http://seer.cancer.gov/faststats/selections.php?#Output.
- http://eco.iarc.fr/eucan/Cancer.aspx?Cancer=15
- http://globocan.iarc.fr/old/summary_table_site
- http://www.cancerresearchuk.org/cancer-info/cancerstats/types/pancreas/mortality/
- http://www-dep.iarc.fr/nordcan/English/StatsFact.asp?cancer=130&country=0
- http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb2/bb2-chap10.pdf
- Ilic M, Hristina V, Marinkovic J, Kocev N (2013). Pancreatic cancer mortality in Serbia from 1991-2010 - a joinpoint analysis. Croat Med J, 54, 369-75. https://doi.org/10.3325/cmj.2013.54.369
- Inal A, Ciltas A, Ramazan Y, Berk V, Kos T, Dane F et al, (2012). Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Medical Oncology Multicenter Study. Asian Pac J Cancer Prev, 13, 1841-4 https://doi.org/10.7314/APJCP.2012.13.5.1841
- Luke C, Price T, Singhal N, Roder D (2009). Pancreatic cancer epidemiology and survival in an Australian population. Asian Pac J Cancer Prev, 10, 369-74
- Lowenfels AB, Maisonneuve P (2006). Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol, 20, 197-209 https://doi.org/10.1016/j.bpg.2005.10.001
- Maissonneuveu P, Lowenfeles AB (2010). Epidemiology of pancreatic cancer: An Update. Dig Dis, 28, 645-56 https://doi.org/10.1159/000320068
- Sant M, Allemani C, Santaquilani M, et al (2009). EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer, 45, 931-91 https://doi.org/10.1016/j.ejca.2008.11.018
- Wood HE, Gupta S, Kang JY, et al (2006). Pancreatic Cancer in England and Wales 1975-2000: patterns and trends in incidence, survival and mortality. Aliment Pharmacol Ther, 23, 1205-14 https://doi.org/10.1111/j.1365-2036.2006.02860.x
피인용 문헌
- dietary patterns and risk of pancreatic and renal cancers vol.47, pp.6, 2017, https://doi.org/10.1108/NFS-03-2017-0053